Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4‐diaminopyridine

Overview of attention for article published in Muscle & Nerve, December 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 3,724)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 11 news outlets
blogs: 6 blogs
twitter: 12 X users

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages
reddit: 1 Redditor

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 6 posts from 6 blogs.

A Drug to Treat a Rare Disease Used to Cost Patients $0. Now, It's $375,000—And Sanders Is Demanding Answers

Common Dreams - Breaking News & Views for the Progressive Community, 04 Feb 2019

Jessica Corbett, staff writerSen. Bernie Sanders (I-Vt.), who has strongly advocated for a massive overhaul of the nation's…

Thinking straight about orphan drugs, Part 3.

The Incidental Economist, 06 Sep 2016

In my last post, I argued that the benefits of the Orphan Drug Act are more elusive than commonly assumed. But what are its…

Jacobus and Catalyst Continue to Race for Approval of LEMS Drug

Bill of Health, 22 Feb 2016

By Dalia Deak The latest development in the race for approval between Jacobus Pharmaceutical Company and Catalyst…

Another old drug is about to get a supersized price

Health | 89.3 KPCC, 23 Dec 2015

; Credit: Bull's Eye/Imagezoo/Getty…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 2 additional blog posts.